Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alisma decoction
- Development stage
- Preclinical
- Lead developer
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Alisma decoction (also known as Ze Xie Tang) is a traditional Chinese medicine (TCM) herbal formula primarily composed of Alisma plantago-aquatica (Ze Xie) and Atractylodes macrocephala (Bai Zhu). It is historically documented in the 'Essentials from the Golden Cabinet' (Jin Gui Yao Lue) by Zhang Zhongjing. The decoction is traditionally used to treat phlegm-fluid retention, dizziness, vertigo, and Meniere's disease by promoting urination, draining dampness, and strengthening the spleen. Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine has evaluated Alisma decoction in clinical trials for the treatment of acute-stage Meniere's disease.
- Other names
- Alisma DecoctionAlisma and Rhizoma decoctionZe Xie TangZexie decoctionZexie Tang
Beyond the preview
Go deeper on Alisma decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alisma decoction.